53 related articles for article (PubMed ID: 2599073)
1. [The specific binding of dihydroalprenolol and quinuclidinyl benzilate with myocardial lysosomes].
Sysoliatina NA; Tomilenko VI
Farmakol Toksikol; 1989; 52(5):28-31. PubMed ID: 2599073
[TBL] [Abstract][Full Text] [Related]
2. Binding of [3H]dihydroalprenolol and [3H]quinuclidinyl benzilate to intact cells of cultured corneal epithelium.
Colley AM; Cavanagh HD
Metab Pediatr Syst Ophthalmol; 1982; 6(2):75-86. PubMed ID: 7162429
[TBL] [Abstract][Full Text] [Related]
3. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
4. An approach to analysis of radiolabeled ligand interactions with specific receptors.
Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
Eur J Pharmacol; 1999 Dec; 386(2-3):279-88. PubMed ID: 10618480
[TBL] [Abstract][Full Text] [Related]
5. The uptake of amines by polymorphonuclear leukocytes.
Dulis BH; Wilson IB
Biochim Biophys Acta; 1981 May; 643(2):398-406. PubMed ID: 7225388
[TBL] [Abstract][Full Text] [Related]
6. Topography of 3H-DHA, 3H-QNB, 3H-dopamine, and 3H-DAGO binding sites distribution in the central part of the sinoatrial node in rat heart.
Sutyagin PV; Kalinina EE; Pylaev AS
Bull Exp Biol Med; 2005 Oct; 140(4):468-72. PubMed ID: 16671583
[TBL] [Abstract][Full Text] [Related]
7. Alterations in cardiac alpha and beta adrenoceptors during the development of spontaneous hypertension.
Yamada S; Ishima T; Tomita T; Hayashi M; Okada T; Hayashi E
J Pharmacol Exp Ther; 1984 Feb; 228(2):454-60. PubMed ID: 6141284
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a circadian-phase-dependency in 3H-dihydroalprenolol binding and cyclic AMP content in heart ventricles of L-D-synchronized rats.
Lemmer B; Lang PH
Pol J Pharmacol Pharm; 1984; 36(2-3):275-80. PubMed ID: 6089160
[TBL] [Abstract][Full Text] [Related]
9. Interactions of radiolabelled ligands with specific receptors: an analysis.
Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
Membr Cell Biol; 2000; 13(5):667-85. PubMed ID: 10987390
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
Zimmerman TW; Binder HJ
Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
Mittal CK
Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
[No Abstract] [Full Text] [Related]
12. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
13. [The effect of antihistaminic preparations on the binding of labelled mepyramine, ketanserin and quinuclidinyl benzilate in the rat brain].
Gankina EM; Porodenko NV; Kondratenko TI; Severin ES; Kaminka ME; Mashkovskiĭ MD
Eksp Klin Farmakol; 1993; 56(1):22-4. PubMed ID: 8100727
[TBL] [Abstract][Full Text] [Related]
14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
15. [The characteristics of the binding of M-cholinergic blockers and beta-adrenoblockers by the brain synaptosomes of 15-day-old and adult rats].
Manukhin BN; Kichikulova TP; Moskovkin GN
Zh Evol Biokhim Fiziol; 1994; 30(4):525-31. PubMed ID: 7863744
[TBL] [Abstract][Full Text] [Related]
16. Evidence for muscarinic receptors on rat colonic epithelial cells: binding of [3H]quinuclidinyl benzilate.
Rimele TJ; O'Dorisio MS; Gaginella TS
J Pharmacol Exp Ther; 1981 Aug; 218(2):426-34. PubMed ID: 7252842
[TBL] [Abstract][Full Text] [Related]
17. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
Wang JX; Mei L; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
[TBL] [Abstract][Full Text] [Related]
18. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
19. [The action of high temperature on beta-adrenoreceptor activity and catecholamine synthesis].
Manukhin BN; Sultanov FF; Shaĭymov BK; Mezidova KhA
Fiziol Zh SSSR Im I M Sechenova; 1992 Apr; 78(4):102-7. PubMed ID: 1334853
[TBL] [Abstract][Full Text] [Related]
20. Kindled seizures selectively reduce a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat dentate gyrus.
Savage DD; McNamara JO
J Pharmacol Exp Ther; 1982 Sep; 222(3):670-3. PubMed ID: 7108770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
